Administration of enoximone in cardiogenic shock
- 1 September 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (7) , 419-423
- https://doi.org/10.1016/0002-9149(88)90970-8
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.Circulation, 1986
- Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failureAmerican Heart Journal, 1984
- Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failureAmerican Heart Journal, 1984
- Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patientsJournal of the American College of Cardiology, 1984
- Administration of Sulmazol in Low-output States following Cardiac SurgeryChest, 1984
- ShockArchives of internal medicine (1960), 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenolAmerican Heart Journal, 1983
- Cardiogenic ShockChest, 1983
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979